Glaxosmithkline Pharmaceuticals consolidated net profit rises 16.09% in the September 2024 quarter

Net profit of Glaxosmithkline Pharmaceuticals rose 16.09% to Rs 252.50 crore in the quarter ended September 2024 as against Rs 217.51 crore during the previous quarter ended September 2023. Sales rose 5.62% to Rs 1010.77 crore in the quarter ended September 2024 as against Rs 956.99 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	1010.77	956.99	6
OPM %	31.83	30.25	-
PBDT	355.98	317.27	12
PBT	339.12	299.16	13
NP	252.50	217.51	16